Rizatriptan for the acute treatment of migraine: Consistency, preference, satisfaction, and quality of life

References

• FerrariMDRoonKILiptonRBGoadsbyPJOral triptans in acute migraine treatment: a meta-analysis of 53 trialsCephalalgia20022263365812383060
   PubMed Web of Science ®Google Scholar
• DowsonJATepperSJDahlofCPatients’ preference for triptans and other medications as a tool for assessing the efficacy of acute treatments for migraineJ Headache Pain2005611212016355291
   PubMedGoogle Scholar
• DahlofCGHLiptonRBMcCarrollKAKramerMSLinesCRFerrariMDWithin-patient consistency of response of rizatriptan for treating migraineNeurology2000551511151611094106
   PubMed Web of Science ®Google Scholar
• BlockGAGoldsteinJPolisAReinesSASmithMEthe Rizatriptan Multicenter Study GroupsEfficacy and safety of rizatriptan versus standard care during long-term treatment for migraineHeadache19983876477111284464
   PubMed Web of Science ®Google Scholar
• GöbelHHeinzeAHeinze-KuhnKLindnerVEfficacy and tolerability of rizatriptan 10mg in migraine: experience with 70 527 patient episodesHeadache20014126427011264686
   PubMed Web of Science ®Google Scholar
• LáinezMJEversSKingeEPreference for rizatriptan 10-mg wafer vs eletriptan 40-mg tablet for acute treatment of migraineCephalalgia20062624625616472330
   PubMed Web of Science ®Google Scholar
• LoderEBrandesJLSilbersteinSRizatriptan Protocol 060 Study GroupPreference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraineHeadache20014174575311576197
   PubMed Web of Science ®Google Scholar
• PascualJBussoneGHernandezJFAllenCVrijensFPatelKRizatriptan-Sumatriptan Preference Study GroupComparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraineEur Neurol20014527528311385269
   PubMed Web of Science ®Google Scholar
• DíezFIStraubeAZanchinGPatient preference in migraine therapy. A randomized, open-label, crossover clinical trial of acute treatment of migraine with oral almotriptan and rizatriptanJ Neurol200725424224917334957
   PubMed Web of Science ®Google Scholar
• Ng-MakDSHuXHChenYMaLSolomonGTimes to pain relief and pain freedom with rizatriptan 10 mg and other oral triptansInt J Clin Pract2007611091111117537184
   PubMed Web of Science ®Google Scholar
• AdelmanJUMannixLKVon SeggernRLRizatriptan tablet versus wafer: patient preferenceHeadache20004037137210849030
   PubMed Web of Science ®Google Scholar
• ChristieSGöbelHMateosVAllenCVrijensFShivaprakashMRizatriptan-Ergotamine/Caffeine Preference Study GroupCrossover comparison of efficacy and preference for rizatriptan 10mg versus ergotamine/caffeine in migraineEur Neurol200349202912464714
   PubMed Web of Science ®Google Scholar
• PascualJGarcía-MoncóCRoigCYusta IzquierdoALópez-GilAeMAX Study GroupRizatriptan 10-mg wafer versus usual nontriptan therapy for migraine: Analysis of Return to Function and Patient PreferenceHeadache2005451140115016178944
   PubMed Web of Science ®Google Scholar
• BellCFFoleyKABarlasSSolomonGHuXHTime to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: A multicenter, prospective, open-label, two-attack, crossover studyClin Ther20062887288016860170
   PubMed Web of Science ®Google Scholar
• LáinezMJALopezAPacualAMEffects on productivity and quality of life of rizatriptan for acute migraine: a workplace studyHeadache20054588389015985105
   PubMed Web of Science ®Google Scholar
• GoldsteinJRyanRJiangKCrossover comparison of rizatriptan 5mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraineHeadache19983873774711284462
   PubMed Web of Science ®Google Scholar
• BomhofMPazJLeggNAllenCVandormaelKPatelKComparison of rizatriptan 10 mg vs naratriptan 2.5 mg in migraineEur Neurol19994217317910529545
   PubMed Web of Science ®Google Scholar
• FreitagFTaylorFHamidMElimination of migraine associated nausea in patients treated with rizatriptan orally disintegrating tablet: a randomized double blind placebo controlled studyHeadache20084836837718047500
   PubMed Web of Science ®Google Scholar
• KramerMMatzura-WolfeDPolisAA placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacksNeurology1998517737819748025
   PubMed Web of Science ®Google Scholar
• PascualJVegaPDienerHAllenCVrijensFPatelKComparison of rizatriptan 10 mg vs zolmitriptan 2.5 mg in the acute treatment of migraineCephalalgia20002045546111037741
   PubMed Web of Science ®Google Scholar
• Tfelt-HansenPTeallJRodriguezFOral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraineHeadache19983874875511284463
   PubMed Web of Science ®Google Scholar
• SantanelloNPolisAHartmaierSKramerMBlockGSilbersteinSImprovement in migraine specific quality of life in a clinical trial of rizatriptanCephalalgia1997178678729453276
   PubMed Web of Science ®Google Scholar
• TeallJTuchmanMCutlerNRizatriptan for the acute treatment of migraine and migraine recurrence. A placebo controlled, outpatient studyHeadache1998382812879595867
   PubMed Web of Science ®Google Scholar
• AhrensSFarmerMWilliamsDEfficacy and safety of rizatriptan wafer for the acute treatment of migraineCephalalgia19991952553010403069
   PubMed Web of Science ®Google Scholar
• GerthWRugglesKStarkSDaviesGSantanelloNImprovement in health related quality of life with rizatriptan 10 mg compared with standard migraine therapyClin Drug Invest200121853860
   Web of Science ®Google Scholar
• CutlerNMushetGDavisRClementsBWhitcherLOral sumatriptan for the acute treatment of migraine: evaluation of three dosage strengthsNeurology1995458 Suppl 7S5S97644082
   PubMed Web of Science ®Google Scholar
• MathewNAsqharnejadMPeykamianMLaurenzaANaratriptan is effective and well tolerated in the acute treatment of migraineNeurology199749148514909409334
   PubMed Web of Science ®Google Scholar